stockrowAmylyx Pharmaceuticals, Inc. (AMLX) vs Perrigo Company plc (PRGO)
- Amylyx Pharmaceuticals, Inc. AMLX 28.12 +1.81%
- Perrigo Company plc PRGO 15.57 −0.89%
Amylyx Pharmaceuticals, Inc. and Perrigo Company plc are both Drug Manufacturers Specialty & Generic companies. Amylyx Pharmaceuticals, Inc. is the larger, with a market value of $3.5B against $2.2B — 1.6× the size. Perrigo Company plc grew revenue faster over the last twelve months: −4.47% against −77.1%. Amylyx Pharmaceuticals, Inc. has the higher net margin (0.00% vs −43.3%) and the higher return on invested capital (0.00% vs −19.0%). Across the 17 metrics below, Perrigo Company plc leads on 10 and Amylyx Pharmaceuticals, Inc. on 7.
Valuation
Profitability
| Metric | AMLX | PRGO | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | (42.65%) | 32.33% | 53.51% |
| Operating margin | 0.00% | (39.43%) | 0.00% |
| Net margin | 0.00% | (43.27%) | (2.45%) |
| Free cash flow margin | 0.00% | 4.11% | 0.00% |
| Return on equity | (74.73%) | (51.39%) | (0.80%) |
| Return on assets | (66.25%) | (20.15%) | (1.67%) |
| Return on invested capital | 0.00% | (19.03%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack